S&P 500
(-0.21%) 5 051.41 points
Dow Jones
(0.17%) 37 799 points
Nasdaq
(-0.12%) 15 865 points
Oil
(-0.01%) $85.35
Gas
(-3.06%) $1.679
Gold
(-0.35%) $2 399.40
Silver
(-0.60%) $28.21
Platinum
(-0.51%) $970.20
USD/EUR
(0.11%) $0.942
USD/NOK
(0.49%) $10.99
USD/GBP
(0.16%) $0.805
USD/RUB
(0.68%) $94.14

Realtime updates for Acacia Pharma Group PLC [ACPH.BR]

Exchange: EURONEXT Industry: Biotechnology
Last Updated31 Dec 1970 @ 19:00

0.00% $ 0.888

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Acacia Pharma Group plc discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, invasive procedures, or chemotherapy treatments in the United States and internationally...

Stats
Today's Volume 761 376
Average Volume 402 314
Market Cap 0.00
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.396
ATR14 $0 (0.00%)

Acacia Pharma Group PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acacia Pharma Group PLC Financials

Annual 2021
Revenue: $1.16M
Gross Profit: $868 000 (74.63 %)
EPS: $-0.840
Q4 2018
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0663
Q3 2018
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0554
Q4 2017
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0277

Financial Reports:

No articles found.

Acacia Pharma Group PLC

Acacia Pharma Group plc discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, invasive procedures, or chemotherapy treatments in the United States and internationally. The company's lead product is BARHEMSYS, an intravenous amisulpride for the treatment and prophylaxis of post-operative nausea and vomiting. Its products also include BYFAVO, an intravenous remimazolam and reversible IV sedative designed for use during invasive medical procedures, such as colonoscopy and bronchoscopy; and APD403, a selective dopamine antagonist amisulpride that has completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting. Acacia Pharma Group plc was founded in 2007 and is based in Cambridge, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators